Institute of environmental science and research - Vedolizumab May Not Worsen COVID-19 Outcomes in IBD Patients

Vedolizumab does not appear to worsen COVID-19 outcomes in patients with IBD, according to data from the Surveillance of Coronavirus Under Research Exclusion for IBD...